The PSA has called on the Medicare Benefits Schedule Review Taskforce to include pharmacist services on the MBS
In its submissions to the taskforce reference groups, the PSA focused on the inclusion of pharmacist services on the MBS to ensure pharmacists are no longer excluded from the rest of the allied healthcare workforce in the delivery of consultation based services upon referral from a general practitioner.
The PSA’s recommendations stem from its two recent reports, Medicine Safety: Take Care and Pharmacists in 2023.
Both the reports advocate for the empowerment of pharmacists to do more than the current healthcare system allows, by harnessing their skills and expertise as medicine experts.
PSA says it is the organisation’s firm view that pharmacists must be involved in the care of patients whenever medicines are part of their health management plan, and particularly in the context of chronic disease management.
PSA National President Dr Chris Freeman said although the Allied Health Reference Group recommended this action in February following previous PSA submissions, there is still more work to be done.
These recommendations out for consultation must make their way to the Minister for Health’s office and once and for all cease the exclusion of pharmacist access to the Medicare Benefits Schedule, he said.
“PSA has advocated over many years to develop funding models to reflect pharmacists’ extensive expertise and contribution to Australia’s health,” said Dr Freeman.
“Pharmacists have been calling for access to the MBS to reflect their skills, training and experience for longer than many of us can remember.
“While this recommendation now exists, it is focused on long-term implementation. Given the rate of medicine-related harm being experienced by Australians and the potential for pharmacists to contribute to medicine safety and quality use of medicines, it is critical that the implementation of this recommendation is not delayed,” Dr Freeman said.
The inclusion of pharmacists in allied healthcare teams is particularly important for vulnerable population groups including Aboriginal and Torres Strait Islander people, PSA said.
In writing to the Aboriginal and Torres Strait Islander Health Reference Group, PSA noted the current issues relating to medication adherence. Pharmacists can make a significant contribution to support adherence through the provision of medicine information, assessing each person’s needs and tailoring solutions accordingly, it said.
Pharmacists also have a key role to play in mental health care teams. PSA said it supports recommendations from the Mental Health Reference Group to encourage coordinated support for patients with chronic and mental illnesses and access to mental health services in residential aged care.
PSA said it believes that pharmacists should have a role in delivering care as part of a mental health care plan, particularly where medication forms part of the patient’s treatment plan – particularly relevant for mental health care services in residential aged care.
“We look forward to continuing to work with the groups involved in the MBS Review as they undertake their consultation on these recommendations, and then working with the Minister for Health to make these recommendations a reality,” Dr Freeman said.